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Abstract Since the 1990s, one of the methods used for
treating fecal incontinence due to internal anal sphincter
defects has been the injection of bulking agents. The aim of
this paper is to report two cases of local giant cell foreign
body reaction after injection of PTQTM in humans. To the
best of the authors’ knowledge, this is the first report of an
adverse immune response to silicone injection in humans.
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Introduction
Fecal incontinence is a socially disabling condition with an
adverse affect on quality of life, for which several surgical
treatments are available. The etiology is often multifacto-
rial, and loss of stool or fecal soiling may be the result of
one or more alterations of the mechanisms that normally
assure continence. The internal anal sphincter (IAS) and the
vascular cushions in the anal canal make the largest con-
tribution to anal resting pressure. Damage to the IAS may
not always cause complete incontinence but may result in
passive fecal incontinence due to a poor anal seal. This may
be visualized by endosonography as an anatomical irregu-
larity of the anal canal, known as a keyhole defect, or a
decrease in thickness. Anorectal manometry values are
usually within the normal range. Injectable bulking agents
have become a treatment option with the introduction of
minimally invasive procedures. In 1993, injection of poly-
tetrafluoroethylene was introduced by Shafik [1]. Since
then, autologous fat, glutaraldehyde cross-linked collagen,
pyrolytic carbon-coated beads, synthetic calcium hydrox-
ylapatite ceramic microspheres, Teflon and a silicone bio-
material (PTQTM, Uroplasty BV, Geleen, The Netherlands)
have been injected. Injecting a bulking agent around the
IAS or into the keyhole defect provides an increased pres-
sure improving the seal and restoring the symmetry of the
anal canal. Reported problems with the use of bulking
agents are deterioration over time and migration, absorp-
tion, and deformation of implants.
Our center uses PTQTM implants. This product is a
heterogeneous injectable material consisting of poly-
dimethylsiloxane particles suspended in a bioexcretable
carrier hydrogel of polyvinylpyrrolidone (Povidone, PVP).
Over 99 volumetric percentages of the particles are larger
than 80 lm. This size is most likely larger than the max-
imum size of particles ingested by macrophages. Giant
cells are able to amass much cytoplasm, but should have
difficulty engulfing these particles. Furthermore, it is
unlikely that these large particles could gain direct access
to lymphatic and small vessels [2]. An inflammatory
reaction to the implant material has been reported in rats by
Nijhuis [3] and in dogs by Smith [4]. We report two cases
of local giant cell foreign body reaction after injection of
PTQTM in humans.
Case 1
A 55-year-old male with fecal soiling and incontinence for
flatus was treated twice with PTQTM in 2005 and 2006.
This patient had had several surgical interventions for anal
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fissures and soiling in other centers. Anal fissures were
treated with Lord’s procedure and lateral sphincterotomy,
and an anal repair was performed to restore the sphinc-
tercomplex. A rectal prolapse was corrected by rectopexy.
Preoperative investigations were performed. A bowel habit
diary showed incidental loss of stool and daily soiling.
Anorectal manometry revealed a low resting pressure of
44 mmHg, but otherwise normal values. Defecography
showed incontinence, without other abnormalities. Puden-
dal nerve terminal motor latency (PNTML) revealed nor-
mal latency values. Endosonography showed scarring of
the IAS from 1 to 6 o’clock and a defect in the external
anal sphincter (EAS) from 9 to 11 o’clock. Injection of
PTQTM in this defect did initially improve continence, but
6 months later, the patient was put on the waiting list for an
artificial bowel sphincter (ABS) due to leakage of stool. In
early 2008, patient visited our institution with severe
complaints of pain in the anal region. A MRI scan showed
multiple abscesses in the perineal area, a subsphincteric
connection with the anus, and a large defect in the IAS and
EAS from 9 to 3 o’clock. Resection of these lesions
revealed a total of six cyst-like tumors positioned in a
chain. The defect was closed, and 2 months later, the ABS
was implanted.
The pathology department received three tissue frag-
ments of varying sizes. The largest piece had a size of
2.5 9 1.5 cm. These specimens were solid in consistency.
Microscopic examination showed a hypercellular inflam-
matory infiltrate, partially surrounded by fibrous connec-
tive tissue. This inflammatory infiltrate was heterogeneous
in composition, consisting mainly of giant cells (Fig. 1).
These giant cells were multinucleated cells, containing
foreign material in their cytoplasm. This foreign material,
which had an oily appearance, did not polarize. Besides
giant cells, foamy macrophages and some lymphocytes
were seen.
Case 2
A 58-year-old male with a 33-year history of pain in the
anal region after abscess and fistula surgery was treated
with PTQTM in 2007 for soiling. Preoperative investiga-
tions were performed. A bowel habit diary showed no loss
of stool and daily soiling. Defecography showed no
abnormalities. Pudendal nerve terminal latency revealed
normal latency values. Anorectal manometry was normal,
resting pressure was 91 mmHg, and squeeze pressure was
214 mmHg. Endosonography showed excessive scarring of
the IAS and a keyhole defect dorsally. Injection of PTQTM
in the defect did not improve continence, and patient was
started on retrograde colonic irrigation to treat soiling and
occasional loss of stool. Persisting pain led to an MRI scan,
which demonstrated a dorsal defect in the anal canal
between 3 and 6 o’clock with a central fluid collection.
This collection had a connection with a second inter-
sphincteric fluid collection. A third and fourth conjoined
collection were seen behind the musculus puborectalis.
When the fluid was removed, a total of four cyst-like
tumors positioned in a chain were revealed. The anal pain
remained and continence was maintained with irrigation.
The pathology department received 4 irregular tissue
fragments with a maximal size of 3 cm. These specimens
consisted of fibrous tissue without any anal or rectal
mucosa. Microscopic examination revealed a similar pic-
ture as in the previous patient: samples showed a foreign
body reaction with presence of numerous giant cells, sur-
rounding similar foreign material (Fig. 2).
Fig. 1 This photograph shows a foreign body reaction with presence
of numerous giant cells (H/E, 50x)
Fig. 2 Large magnification reveals the presence of giant cells and
foamy macrophages. The giant cells contain foreign material, which
has an oily appearance (H/E, 200x)
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Discussion
Since the introduction of bulking agents to improve con-
tinence in patients with an IAS defect, results have been
mixed and a functional deterioration after 2 years has been
reported [5]. In a systematic review, Luo et al. concluded
that there is currently little evidence for the effectiveness of
injectable bulking agents in managing passive flatus
incontinence [6]. Furthermore, they concluded that the
identified injectable bulking agents appeared to be safe
with only minor complications reported. Migration of
bulking agent was described in 14 out of 420 patients (3%,
12 out of 208 with PTQTM). No foreign body reaction was
reported. Similar conclusions were drawn by Maeda et al.
in a Cochrane review [7]. Reviews published in the field of
urology do not report any foreign body reaction to silicone
implants [8, 9]. In vivo studies in animals have shown
quiescent to marked foreign body inflammatory reactions
as part of encapsulating the product in the first few weeks
after injection [3, 4, 10].
Our center has performed approximately 50 PTQTM
procedures, and literature describes approximately 260
patients. We feel this number of patients is too small to
serve as a basis for speculation about the incidence of this
rare medium-term adverse immune response.
This is, to the best of our knowledge, the first report on
an adverse immune response to silicone injection for fecal
incontinence in humans. Surgeons considering the use of
PTQTM need to be aware of the possibility of an adverse
immune response to this product.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
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